CN104127505A - 一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺 - Google Patents
一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺 Download PDFInfo
- Publication number
- CN104127505A CN104127505A CN201410317736.1A CN201410317736A CN104127505A CN 104127505 A CN104127505 A CN 104127505A CN 201410317736 A CN201410317736 A CN 201410317736A CN 104127505 A CN104127505 A CN 104127505A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese patent
- patent medicine
- medicine
- bee
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 72
- 239000008187 granular material Substances 0.000 title claims abstract description 25
- 238000005516 engineering process Methods 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 201000010099 disease Diseases 0.000 title abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 51
- 238000011282 treatment Methods 0.000 claims description 28
- 239000010231 banlangen Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 21
- 235000015165 citric acid Nutrition 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 11
- 244000246386 Mentha pulegium Species 0.000 claims description 11
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 11
- 239000000686 essence Substances 0.000 claims description 11
- 235000001050 hortel pimenta Nutrition 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 abstract description 11
- 239000002253 acid Substances 0.000 abstract description 4
- 239000000575 pesticide Substances 0.000 abstract description 3
- 239000000273 veterinary drug Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 241000256844 Apis mellifera Species 0.000 description 42
- 230000000694 effects Effects 0.000 description 20
- 241000256836 Apis Species 0.000 description 10
- -1 alkaloid polysaccharide Chemical class 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002075 main ingredient Substances 0.000 description 5
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 4
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 4
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 4
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 4
- APTNOIWSCDBIAS-UHFFFAOYSA-N 5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C(O)C(O)C(CO)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C APTNOIWSCDBIAS-UHFFFAOYSA-N 0.000 description 4
- IYMNRCWUEDWTPE-UHFFFAOYSA-N 5-hydroxy-2-(2-hydroxy-6-methoxyphenyl)-7,8-dimethoxychromen-4-one Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C=C(OC)C(OC)=C2O1 IYMNRCWUEDWTPE-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 4
- KZJWDPNRJALLNS-FBZNIEFRSA-N clionasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-FBZNIEFRSA-N 0.000 description 4
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 3
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 3
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- 229940097275 indigo Drugs 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000002378 plant sterols Nutrition 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 2
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 2
- LFJQCDVYDGGFCH-JTQLQIEISA-N (+)-β-phellandrene Chemical compound CC(C)[C@@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-JTQLQIEISA-N 0.000 description 2
- LFJQCDVYDGGFCH-SNVBAGLBSA-N (+/-)-beta-Phellandrene Natural products CC(C)[C@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-SNVBAGLBSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- NUNODKNZSZKXGY-LBPRGKRZSA-N (2s)-5,7,8-trihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=C(O)C(O)=CC(O)=C2C(=O)C1 NUNODKNZSZKXGY-LBPRGKRZSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 2
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- JCBLOUSNKOCZTD-UHFFFAOYSA-N 4-hydroxy-3-(2-methylprop-1-enyl)naphthalene-1,2-dione Chemical compound C1=CC=C2C(=O)C(=O)C(C=C(C)C)=C(O)C2=C1 JCBLOUSNKOCZTD-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 2
- 241000134874 Geraniales Species 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- MZSGWZGPESCJAN-MOBFUUNNSA-N Melitric acid A Natural products O([C@@H](C(=O)O)Cc1cc(O)c(O)cc1)C(=O)/C=C/c1cc(O)c(O/C(/C(=O)O)=C/c2cc(O)c(O)cc2)cc1 MZSGWZGPESCJAN-MOBFUUNNSA-N 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 239000004100 Oxytetracycline Substances 0.000 description 2
- HFNGSIBHHMFWQB-UHFFFAOYSA-N Platycogenic acid A Natural products C1C(O)C(O)C(CO)(C(O)=O)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C HFNGSIBHHMFWQB-UHFFFAOYSA-N 0.000 description 2
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- KGGGRGBDMBZXKF-UHFFFAOYSA-N Virganreagenin G Natural products C1C(O)C(O)C(C)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C KGGGRGBDMBZXKF-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 2
- 235000008714 apigenin Nutrition 0.000 description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 210000004666 bacterial spore Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- LFJQCDVYDGGFCH-UHFFFAOYSA-N beta-phellandrene Natural products CC(C)C1CCC(=C)C=C1 LFJQCDVYDGGFCH-UHFFFAOYSA-N 0.000 description 2
- 229930006722 beta-pinene Natural products 0.000 description 2
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 229930006739 camphene Natural products 0.000 description 2
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 2
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000003640 drug residue Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- SBHXYTNGIZCORC-ZDUSSCGKSA-N eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 2
- TUJPOVKMHCLXEL-UHFFFAOYSA-N eriodictyol Natural products C1C(=O)C2=CC(O)=CC(O)=C2OC1C1=CC=C(O)C(O)=C1 TUJPOVKMHCLXEL-UHFFFAOYSA-N 0.000 description 2
- 235000011797 eriodictyol Nutrition 0.000 description 2
- SBHXYTNGIZCORC-UHFFFAOYSA-N eriodyctiol Natural products O1C2=CC(O)=CC(O)=C2C(=O)CC1C1=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NUNODKNZSZKXGY-UHFFFAOYSA-N isocarthamidin Natural products C1=CC(O)=CC=C1C1OC2=C(O)C(O)=CC(O)=C2C(=O)C1 NUNODKNZSZKXGY-UHFFFAOYSA-N 0.000 description 2
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229930007503 menthone Natural products 0.000 description 2
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 2
- 235000007625 naringenin Nutrition 0.000 description 2
- 229940117954 naringenin Drugs 0.000 description 2
- HXRBQSOSCSKMTM-UHFFFAOYSA-N nor-lapachol Natural products C1=CC=C2C(=O)C(C=C(C)C)=C(O)C(=O)C2=C1 HXRBQSOSCSKMTM-UHFFFAOYSA-N 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 2
- 229960000625 oxytetracycline Drugs 0.000 description 2
- 235000019366 oxytetracycline Nutrition 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- DJHDOMQWAUJNKX-UHFFFAOYSA-N phillygenin Natural products COc1ccc(cc1O)C2OCC3C2COC3c4ccc(OC)c(OC)c4 DJHDOMQWAUJNKX-UHFFFAOYSA-N 0.000 description 2
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 2
- 235000007221 pinoresinol Nutrition 0.000 description 2
- QKFAFSGJTMHRRY-FVDOMRANSA-M potassium;[(z)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N/OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-FVDOMRANSA-M 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- CPJKKWDCUOOTEW-UHFFFAOYSA-N sylvatesmin Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(O)=CC=3)C2CO1 CPJKKWDCUOOTEW-UHFFFAOYSA-N 0.000 description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 2
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- WUOACPNHFRMFPN-VIFPVBQESA-N (R)-(+)-alpha-terpineol Chemical compound CC1=CC[C@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-VIFPVBQESA-N 0.000 description 1
- UZQVYLOFLQICCT-SCSAIBSYSA-N (R)-goitrin Chemical compound C=C[C@@H]1CNC(=S)O1 UZQVYLOFLQICCT-SCSAIBSYSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- OSUJYLRDFDGEHZ-UHFFFAOYSA-N 3,7-dimethylocta-1,3,6-triene Chemical compound CC(C)=CCC=C(C)C=C.CC(C)=CCC=C(C)C=C OSUJYLRDFDGEHZ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- JZVFJDZBLUFKCA-ZXLWUMLCSA-N Chondrillasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-ZXLWUMLCSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- GQEVCHQXWPWARL-UHFFFAOYSA-N Couroupitine A Natural products N1=CC=CC2=CC(=O)N3C4=CC=CC=C4C(=O)C3=C21 GQEVCHQXWPWARL-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UZQVYLOFLQICCT-UHFFFAOYSA-N Goitrin Natural products C=CC1CNC(=S)O1 UZQVYLOFLQICCT-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- PWUCIPXNTHJNJC-UHFFFAOYSA-N Matairesinoside Natural products COc1cc(CC2C(Cc3ccc(OC4OC(CO)C(O)C(O)C4O)c(OC)c3)CCC2=O)ccc1O PWUCIPXNTHJNJC-UHFFFAOYSA-N 0.000 description 1
- AAGCATAPYOEULE-UHFFFAOYSA-N Matairesinoside aglycone Natural products C1=C(O)C(OC)=CC(CC2C(C(=O)OC2)CC=2C=C(OC)C(OC3C(C(O)C(O)C(CO)O3)O)=CC=2)=C1 AAGCATAPYOEULE-UHFFFAOYSA-N 0.000 description 1
- VFFCBWDFYBEZAX-YCRREMRBSA-N Menthoside Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C=C(O3)C=3C=CC(OC(=O)\C=C\C=4C=C(O)C(O)=CC=4)=CC=3)=O)=C(O)C=2)O1 VFFCBWDFYBEZAX-YCRREMRBSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 description 1
- DGNAEYFEAUVDAJ-UHFFFAOYSA-N Platycogenic acid B Natural products CC12CC(O)C(O)C(C)(C(O)=O)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C DGNAEYFEAUVDAJ-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-INYURWPISA-N Poriferasta-7,22E-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-INYURWPISA-N 0.000 description 1
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 1
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 1
- 241001423398 Ruscus hypoglossum Species 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- NPLTVGMLNDMOQE-NSHDSACASA-N carthamidin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-NSHDSACASA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-STIDJNKJSA-N gamma-sitosterol Natural products CC[C@@H](CC[C@@H](C)[C@@H]1CC[C@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C KZJWDPNRJALLNS-STIDJNKJSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940095686 granule product Drugs 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IHFBPDAQLQOCBX-UHFFFAOYSA-N hispidulin Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C=C1 IHFBPDAQLQOCBX-UHFFFAOYSA-N 0.000 description 1
- OETSANFHEJPBHW-UHFFFAOYSA-N hispidulin Natural products COc1cc2c(cc1O)oc(cc2=O)-c1ccc(O)cc1 OETSANFHEJPBHW-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- AAGCATAPYOEULE-LHHMAMHXSA-N matairesinoside Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@H](C(=O)OC2)CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)=C1 AAGCATAPYOEULE-LHHMAMHXSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- XTDAUCLSJYHNGJ-UHFFFAOYSA-N platycogenic acid C Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C XTDAUCLSJYHNGJ-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 229940109990 ruscogenin Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 229930190376 scutellarin Natural products 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 210000004215 spore Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及中成药、兽药技术领域,公开了一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺。该中成药的配方包括以板蓝根、半枝莲、桔梗和连翘组成的主料,以及以柠檬酸和薄荷精组成的辅料,其中,各组分按照重量份分别为:板蓝根30份~50份、半枝莲15份~30份、桔梗15份~30份、连翘10份~20份、柠檬酸2份~5份以及薄荷精2份~5份。本发明具有既能治疗蜜蜂疾病又能避免蜂产品中存在抗生素和农药等残留物的优点。
Description
技术领域
本发明涉及中成药、兽药技术领域,更具体地说,特别涉及一种治疗蜜蜂白垩病、黄曲霉病的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺。
背景技术
依据蜜蜂产品质量安全,蜜蜂产品蜂蜜、蜂王浆、蜂花粉中不得含有抗生素、农药类残留。现有技术中的很多蜂场在治疗白垩病时往往施用四环素、土霉素、链霉素等药物,导致产品中因含有抗生素残留或农药残留而不合格。故而,有必要研究一种新型的药物。
由于板蓝根、半枝莲、桔梗和连翘等具有各种功效,而柠檬酸和薄荷精具有调节适口性和增加免疫作用,它们相互作用功效十分突出,经过发明人检索,现有技术中还未公开关于采用上述产品配方的治疗蜜蜂疾病的白垩净粉剂药物。
1、板蓝根主要成份及功效:(1)成份:板蓝根含靛蓝(indigotin,indigo),靛玉红(indirubin),蒽醌类、β-谷甾醇(β-sitosterol),γ-谷甾醇(γ-sitosterol)以及多种氨基酸:精氨酸(arginine),谷氨酸(glutamic acid),酪氨酸(tyrosine),脯氨酸(proline),缬氨酸(valine),γ-氨基丁酸(γ-aminobu-tyric acid)。还含黑芥子甙(sinigrin),靛甙(indoxyl-β-hlucoside),色胺酮(trptanthrin),1-硫氰酸-2-羟基丁-3-烯(l-thiocyano-2-hydroxy-3-butene),表告伊春(epigoitrin),腺甙(adenosine),棕榈酸(palmitic acid),蔗糖(sucrose)和含有12%氨基酸的蛋白多糖。还含有抗革兰氏阳性和阴性细菌的抑菌物质及动力精。(2)功效:抗菌抗病毒作用;抗钩端螺旋体作用;解毒作用;提高免疫功能,;抗肿瘤作用;对白血病有治疗作用。
2、半枝莲主要成份及功效:(1)成份:全草含红花素(carthamidin),异红花素(iso-carthamidin),高山黄芩素(scutellarein),高山黄钤甙(scutel-larin),β-谷甾醇(β-sitosterol),硬脂酸(steraricacid),生物碱多糖等。另据报道,从地上部分分离得到汉黄芩素(wogo-nin),半枝莲素(scutervulin),半枝莲种素(rivularin),柚皮素(naringenin),芹菜素(apigenin),粗毛豚草素(hispedulin),圣草素(eriodictyol),木犀草素(suteolin),5,7,4-三羟基-8-甲氧基黄烷酮(5,7,-trihydroxy-6-methoxyflavanone)4-羟基汉黄芩素(4-hydroxywogonin),7-闳基-5,8-二甲氧基黄酮(7-hy-droxy-5,8-dimethoxyflavane),对-闳基苯甲西藏(p-hydroxyben-zaldehyde),对-闳基苄基丙酮(p-hydroxybenzylacetone),对-香豆酸(p-coumaricaicd),原儿茶酸(protocatechuicacid),能果酸(ut-solicacid)植物甾醇(phytosterol),植物甾醇β-D-葡萄糖甙(phy-tosteryl-β-D-glucoside)等。(2)功效:治吐血,衄血,血淋,赤痢,黄疸,咽喉疼痛,肺痈,疔疮,瘰疬,疮毒,癌肿,跌打刀伤,蛇咬伤。
3、桔梗的主要成份和功效:(1)成份:含桔梗皂甙(Platycodin),水解产生皂甙元为三萜酸的混合物,其中一种为远志酸(Polygalacic acid),另一种为桔梗皂甙元(Platy-codigenin).尚含桔梗酸A、B及C(Platycogenic acid A、B、C),菊糖,桔梗聚糖,葡萄糖及植物甾醇,如菠菜甾醇(α-Spinasterol)、α-菠菜甾醇-β-D-葡萄糖甙(α-Spinasteryl-β-D- glucoside)等。(2)功效:止咳药、祛痰药。
4、连翘的主要成份和功效:(1)成份:含有连翘酚(Forsythol);连翘甙(Phillyrin)、连翘甙元(Phillygenin);齐墩果酸(Oleanolic acid)、白桦脂酸(Betulinic acid)、熊果酸(Ursolic acid)、松脂素(Pinoresinol)、甾醇化合物C49H70-80O6.马苔树脂醇甙(Matairesinoside),尚含有多种烃类、醛酮类、醇酯醚类挥发性成分:α-蒎烯(α-Pinene)、莰烯(Camphene)、β-蒎烯(β-Pinene)、对聚伞花烯(p-Cymene)、柠檬烯(Limonene)、γ-松油烯(γ-Terpinene)、β-水芹烯(β-Phellandrene)、香叶烯(Myrcene)、β-罗勒烯(β-Ocimene);樟脑(Camphor)、香叶醛(Geranial);龙脑(Borneol)、α-萜品醇(α-Terpineol)、黄樟醚(Safrole)、芳樟醇(Linalool)、松油烯醇-4(Terpinen-4-ol)、去甲拉帕醇(Norlapa- chol)以及香豆素、芦丁等。(2)功效:抗病原微生物作用;抗炎作用;解热作用。
5、柠檬酸的性质和作用:(1)化学性质:从结构上讲柠檬酸是一种三羧酸类化合物,并因此而与其他羧酸有相似的物理和化学性质,加热至175 ℃时它会分解产生二氧化碳和水,剩余一些白色晶体。柠檬酸是一种较强的有机酸,有3个H+可以电离;加热可以分解成多种产物,与酸、碱、甘油等发生反应。(2)作用:用于食品工业:因为柠檬酸有温和爽快的酸味,普遍用于各种饮料、汽水、葡萄酒、糖果、点心、饼干、罐头果汁、乳制品等食品的制造,在所有有机酸的市场中,柠檬酸市场占有率 70%以上,到目前还没有一种可以取代柠檬酸的酸味剂。柠檬酸还有抗氧化作用,也可用作食用油的抗氧化剂。用于杀菌:柠檬酸与80℃温度联合作用具有良好杀灭细菌芽孢的作用,并可有效杀灭血液透析机管路中污染的细菌芽孢。
6、薄荷精(粉)的主要成份和功效:(1)成份:左旋薄荷醇(menthol),含量62.3%~87.2%;在旋薄荷酮(menthone)等。又含黄酮类成分:异瑞福灵(isoraifolin)、薄荷异黄酮苷(mentho side);有机酸成分:迷迭香酸(rosmarinicacid)、咖啡酸(caffeic acid);氨基酸成分:天冬氨酸(asparticacid)、谷氨酸(glutamic acid)。还含二羧基-1,2-二氢荼二羧酸为母核的多种成分:1-(3,4二羟基苯基)-6,7-二羟基-二1,2-二氢荼-2,3-二羧酸〔1-(3,4-dihydroxyp henyl)-6,7-dihydroxy-l,2-dihydronaphthalene-2,3-dicarboxylic acid〕等。(2)功效:薄荷有“热时清凉,冷时暖身”的双重特性,因此可有效地治疗感冒,而它最重要的贡献是在控制消化系统方面的急性症状。并有清凉、镇痛的功效,可减轻头痛、偏头痛以及牙痛。
发明内容
本发明的目的在于提供一种既能治疗蜜蜂白垩病疾病又能避免蜂产品中存在抗生素和农药等残留物的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺。
为了解决以上提出的问题,本发明采用的技术方案为:一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药,该中成药的配方包括以板蓝根、半枝莲、桔梗和连翘组成的主料,以及以柠檬酸和薄荷精组成的辅料,其中,各组分按照重量份分别为:板蓝根30份~50份、半枝莲15份~30份、桔梗15份~30份、连翘10份~20份、柠檬酸2份~5份以及薄荷精2份~5份。
根据本发明的一优选实施例:所述中成药为颗粒状粉剂药物。
本发明还提供一种根据上述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,包括以下步骤:
第一步,将干燥的板蓝根和桔梗切片,分别按1:40比例加置制药工业用反应釜中,进行水煎煮提炼1.5小时~2小时,再分别用40目过滤筛过滤得到板蓝根和桔梗提取物水煎液,另将半枝连、连翘分别进行粉碎,粉碎后分别加入置反应釜中进行水煎煮1小时~1.5小时,分别用60目过滤筛过滤得到半枝莲、连翘提炼提取物水煎液;
第二步,将第一步中得到四种提取物水煎液分别置真空浓缩罐中,进行真空低温浓缩,得到浓缩浸膏,再分别置冷冻干燥机中,在低温-40℃~-80℃中进行冷冻干燥,分别得到四种药物干燥物;
第三步,将第二步中得到的四种药物干燥物分别用药物粉碎机进行粉碎,粉碎后按配方比例将其进行充分混合,然后用80目~100目筛过筛,过筛后,将混合药物粉装入干燥干净器材,贮藏备用;
第四步,将柠檬酸粉、薄荷粉按配方比例所需量加入到第三步中的混合药物粉中,并进行充分混合,得到混合药物粉;
第五步,将第四步中的混合药物粉经过制软料,即在其中加入适量粘合剂,充分混合,制成适宜柔软件,再进入制颗粒工序得到混合药物颗粒,最后将混合药物颗粒置50℃~60℃干燥机中进行干燥得到含水量在3%以下的白垩净中成药。
根据本发明的一优选实施例:所述第一步之前还包括将板蓝根、半枝连、桔梗和连翘四种中草药清洗整理、置干净场所晒干的步骤。
根据本发明的一优选实施例:在第一步中,所述板蓝根和桔梗的切片厚度为2mm。
根据本发明的一优选实施例:所述第二步中的真空浓缩罐中的真空度为0.8mpb。
根据本发明的一优选实施例:所述第五步中的粘合剂为淀粉浆,其加入量为8%~10%。
与现有技术相比,本发明的有益效果在于:
1、在本发明的中成药配方中,板蓝根、半枝莲、桔梗、连翘的提炼提取物干物质占95%,作为蜜蜂内服药物起到杀灭与清除蜜蜂口腔、呼吸道和肠道内真菌性病害(白垩病),阻止真菌繁殖,减缓蜂群蜜蜂个体热症和肿痛,并能增加蜜蜂的抗病性,减少蜂群间的传播,辅助调节中枢神经,快速恢愎蜜蜂体质之功效;
2、在本发明的中成药配方中,以板蓝根、半枝莲、桔梗和连翘提炼提取物干物质为主要原料,再添加柠檬酸和薄荷精,可更好地增加药物在蜜蜂口腔、呼吸道、消化道、排泄系统中杀灭真菌和细菌芽孢作用;
3、在本发明的中成药配方中,采用的是中草药提炼提取物干物质作为主要原料经加工成治疗蜜蜂白垩病的药物,在治疗蜜蜂白垩病时,避免了蜂群因施药而导致蜂产品污染和药物残留,保证了蜂产品的质量安全。
附图说明
图1.为本发明的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的加工方法的流程图。
具体实施方式
下面结合实施例及附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。
本实施例提供一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药,其为颗粒状药物,作为冲剂使用,该中成药的配方包括以板蓝根、半枝莲、桔梗和连翘组成的主料,以及以柠檬酸和薄荷精组成的辅料,其中,各组分按照重量份分别为:板蓝根30份~50份、半枝莲15份~30份、桔梗15份~30份、连翘10份~20份、柠檬酸2份~5份以及薄荷精2 份~5份。
参阅图1所示,本实施提供的一种根据上述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,包括以下步骤:
第一步,将板蓝根、半枝连、桔梗和连翘四种中草药清洗整理、置干净场所晒干;然后将干燥的板蓝根和桔梗切片(厚度约为2mm),按1:40比例加置制药工业用反应釜中,进行水煎煮提炼1.5小时~2小时,再用40目过滤筛过滤得到板蓝根和桔梗提取物水煎液,并将半枝连、连翘分别进行粉碎,粉碎后分别加置反应釜中进行水煎煮1小时~1.5小时,分别用60目过滤筛过滤得到半枝莲、连翘提炼提取物水煎液;
第二步,将第一步中得到四种提取物水煎液分别置真空浓缩罐中(真空度为0.8mpb),进行真空低温浓缩,分别得到浓缩浸膏,再分别置冷冻干燥机中,在低温-40℃~-80℃中进行冷冻干燥,分别得到四种药物干燥物;
第三步,将第二步中得到的四种药物干燥物分别用药物粉碎机进行粉碎,粉碎后按配方比例将其进行充分混合,然后用80目~100目筛过筛,过筛后,将混合药物粉装入干燥干净器材,贮藏备用;
第四步,将柠檬酸粉、薄荷粉按配方比例所需量加入到第三步中的混合药物粉中,并进行充分混合,得到混合药物粉;
第五步,将第四步中的混合药物粉经过制软料,即在其中加入适量8%淀粉浆粘合剂,充分混合制成软料,再进入制颗粒工序,最后将颗粒置50℃~60℃温箱中进行干燥得到含水量3%以下的中成药颗粒。
本发明的中成药用于治疗蜜蜂疾病的主要机理在于:1、充分利用板蓝根、半枝莲、桔梗和连翘的清热解毒、消除肿痛作用,由于在中医药学上,将它们用于内服,主治真菌病引起的肿痛、肠道感染和风热温病、痢疾腹痛等疾病。故而,本发明配方中各药物成分相互作用,阻止真菌繁殖,减缓蜂群蜜蜂个体热症和肿痛;2、在板蓝根、半枝莲、桔梗和连翘为主要原料的配方中,经过提炼将提取物混合,添加柠檬酸、薄荷精各,使蜜蜂中成药冲剂产品更能起到杀灭口腔、呼吸道、上消化道、下消化道及排泄系统真菌、细菌等作用;3、在本发明配方中,添加柠檬酸、薄荷精成分少量,使产品口感柔和、适口性强,使染病蜂群蜜蜂主动吸食,吸收加快,同时还能使产品对蜜蜂生物体起到一定抗疲劳和增强免疫功能,蜂群恢复加快,加快白垩病的治疗;4、本发明采用的是中草药提炼提取物干物质作为主要原料经加工成治疗蜜蜂白垩病的药物,在治疗蜜蜂白垩病时,避免了蜂群因施药而导致蜂产品污染和药物残留,保证了蜂产品的质量安全。
下表1是一组采用本发明的白垩净粉剂中成药治疗蜜蜂疾病与采用现有抗生素治疗蜜蜂疾病在治愈率上的对比试验数据。
表1
以上试验数据表明,使用抗生素治疗白垩病蜂群,7天后,治愈率分别为59%、80%,平均为69.5%。而使用本发明的中成药治疗白垩病蜂群,7天后,治愈率分别为90%、94.7%、91.7%,平均为92.13%,相对于现有抗生素治疗来说,治愈率得到大大的提高。
下表2一组采用本发明的中成药治疗蜜蜂疾病与采用现有抗生素治疗蜜蜂疾病在抗生素残留上的对比试验数据。
表2
以上试验数据表明,使用土霉素、四环素类药物治疗蜜蜂白垩病的蜂群生产的蜂蜜,经检测,抗生素残留含量分别为:1.2μg/kg、1.8μg/kg,为不合格蜂蜜产品。而使用本发明的白垩净粉剂中成药治疗蜜蜂白垩病的蜂群生产的蜂蜜,经检测一致无抗生素残留,蜂蜜商品性完好。
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。
Claims (7)
1.一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药,其特征在于:该中成药的配方包括以板蓝根、半枝莲、桔梗和连翘组成的主料,以及以柠檬酸和薄荷精组成的辅料,其中,各组分按照重量份分别为:板蓝根30份~50份、半枝莲15份~30份、桔梗15份~30份、连翘10份~20份、柠檬酸2份~5份以及薄荷精2份~5份。
2.根据权利要求1所述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药,其特征在于:所述中成药为颗粒状粉剂药物。
3.一种根据权利要求1所述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,其特征在于,该工艺包括以下步骤:
第一步、将干燥的板蓝根和桔梗切片,分别按1:40比例加置制药工业用反应釜中,进行水煎煮提炼1.5小时~2小时,再分别用40目过滤筛过滤得到板蓝根和桔梗提取物水煎液,另将半枝连、连翘分别进行粉碎,粉碎后分别加入置反应釜中进行水煎煮1小时~1.5小时,分别用60目过滤筛过滤得到半枝莲、连翘提炼提取物水煎液;
第二步、将第一步中得到四种提取物水煎液分别置真空浓缩罐中,进行真空低温浓缩,得到浓缩浸膏,再分别置冷冻干燥机中,在低温-40℃~-80℃中进行冷冻干燥,分别得到四种药物干燥物;
第三步、将第二步中得到的四种药物干燥物分别用药物粉碎机进行粉碎,粉碎后按配方比例将其进行充分混合,然后用80目~100目筛过筛,过筛后,将混合药物粉装入干燥干净器材,贮藏备用;
第四步、将柠檬酸粉、薄荷粉按配方比例所需量加入到第三步中的混合药物粉中,并进行充分混合,得到混合药物粉;
第五步、将第四步中的混合药物粉经过制软料,即在其中加入适量粘合剂,充分混合,制成适宜柔软件,再进入制颗粒工序得到混合药物颗粒,最后将混合药物颗粒置50℃~60℃干燥机中进行干燥得到白垩净中成药。
4.根据权利要求3所述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,其特征在于:所述第一步之前还包括将板蓝根、半枝连、桔梗和连翘四种中草药清洗整理、置干净场所晒干的步骤。
5.根据权利要求3所述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,其特征在于:在第一步中,所述板蓝根和桔梗的切片厚度为2mm。
6.根据权利要求3所述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,其特征在于:所述第二步中的真空浓缩罐中的真空度为0.8mpb。
7.根据权利要求3所述的治疗蜜蜂白垩病的白垩净颗粒冲剂中成药的生产工艺,其特征在于:所述第五步中的粘合剂为淀粉浆,其加入量为8%~10%。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410317736.1A CN104127505B (zh) | 2014-07-06 | 2014-07-06 | 一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410317736.1A CN104127505B (zh) | 2014-07-06 | 2014-07-06 | 一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104127505A true CN104127505A (zh) | 2014-11-05 |
| CN104127505B CN104127505B (zh) | 2016-08-31 |
Family
ID=51800527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410317736.1A Expired - Fee Related CN104127505B (zh) | 2014-07-06 | 2014-07-06 | 一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104127505B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267279A (zh) * | 2015-10-12 | 2016-01-27 | 南宁市全健蜜蜂养殖场 | 防治蜜蜂白垩病的中药制剂及其制备方法 |
| CN107625955A (zh) * | 2017-09-21 | 2018-01-26 | 广西吉朋投资有限公司 | 一种蜜蜂防病制剂及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709293A (zh) * | 2004-06-17 | 2005-12-21 | 叶达华 | 一种用于治疗蜜蜂疾病的组合物及药物饲料 |
| CN102273495A (zh) * | 2010-06-11 | 2011-12-14 | 滕纯森 | 保蜂健 |
| CN102836368A (zh) * | 2012-09-10 | 2012-12-26 | 安徽省蜜蜂产业商会 | 一种防治蜂病的中药组合物及其制备方法 |
| KR20130005052A (ko) * | 2011-07-05 | 2013-01-15 | 안길수 | Usb 온열 한약 파우치 |
-
2014
- 2014-07-06 CN CN201410317736.1A patent/CN104127505B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709293A (zh) * | 2004-06-17 | 2005-12-21 | 叶达华 | 一种用于治疗蜜蜂疾病的组合物及药物饲料 |
| CN102273495A (zh) * | 2010-06-11 | 2011-12-14 | 滕纯森 | 保蜂健 |
| KR20130005052A (ko) * | 2011-07-05 | 2013-01-15 | 안길수 | Usb 온열 한약 파우치 |
| CN102836368A (zh) * | 2012-09-10 | 2012-12-26 | 安徽省蜜蜂产业商会 | 一种防治蜂病的中药组合物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 叶俊: "告别误区突出‘防’,把好‘九关’保蜂康——谈谈我是如何防治白垩病的", 《蜜蜂杂志(月刊)》 * |
| 郭芳彬: "蜜蜂白垩病的诊断与防治(续)", 《养蜂科技》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267279A (zh) * | 2015-10-12 | 2016-01-27 | 南宁市全健蜜蜂养殖场 | 防治蜜蜂白垩病的中药制剂及其制备方法 |
| CN105267279B (zh) * | 2015-10-12 | 2019-02-15 | 南宁市全健蜜蜂养殖场 | 防治蜜蜂白垩病的中药制剂及其制备方法 |
| CN107625955A (zh) * | 2017-09-21 | 2018-01-26 | 广西吉朋投资有限公司 | 一种蜜蜂防病制剂及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104127505B (zh) | 2016-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102669331A (zh) | 一种异叶茴芹保健茶 | |
| CN105169012A (zh) | 畜禽用抗病毒中药组合物、发酵中药、制备方法及应用 | |
| CN106132425A (zh) | 包含柑橘类种子提取物的组合物、食品、药品和包含柑橘类种子提取物的组合物制造方法 | |
| CN102885372A (zh) | 一种白灵菇芦荟金银花复合保健饮料及其制作方法 | |
| CN104173453A (zh) | 一种用于防治鸡传染性喉气管炎的中药组合物及其制备方法 | |
| CN104381991A (zh) | 一种破壁灵芝孢子粉灵芝胶囊及其制备方法 | |
| CN104127505B (zh) | 一种治疗蜜蜂白垩病的白垩净颗粒冲剂中成药及生产工艺 | |
| KR100793822B1 (ko) | 생약재 추출물을 함유하는 캔디의 제조방법 | |
| CN101961468B (zh) | 防治猪呼吸道综合症的中药组合物及其应用 | |
| CN104383068B (zh) | 一种高效抗病毒、抑菌的中兽药 | |
| Tiamiyu et al. | Phytochemical Constituents, Nutritional and Antibacterial Potentials of Selected Medicinal Plants | |
| CN106234475A (zh) | 一种临床微生物检验用中药消毒剂 | |
| CN105250460A (zh) | 一种治疗兔腹泻的药物组合物及其制备方法 | |
| CN104524016B (zh) | 防治鸡病毒性产蛋率下降的中草药组合物 | |
| CN103805428A (zh) | 一种蓝莓生津止渴酒及生产方法 | |
| CN108057115A (zh) | 一种治疗上呼吸道炎症感染的组合物及其制备方法 | |
| CN104161817B (zh) | 一种用于防治鸡细菌性疾病的复方中药组合物及其制备方法 | |
| CN104161986A (zh) | 一种用于防治禽流感的中药组合物及其制备方法和应用 | |
| CN107998280A (zh) | 一种家禽用抗生素替代品及其制备方法与应用 | |
| CN101248837A (zh) | 天然五草植物抗菌抗禽流感功能性饲料添加剂 | |
| CN102524490A (zh) | 美人香体制品及其制备方法 | |
| CN109893641B (zh) | 一种具有清咽润喉功能的直接入口生姜粉及其制备方法 | |
| CN107233486A (zh) | 一种治疗咽炎的老盐柠檬组合物及其制备方法 | |
| CN119925481B (zh) | 一种用于呼吸道健康的化橘红粉及其制备方法和应用 | |
| CN105661224A (zh) | 一种含有乳杆菌的饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170103 Address after: 430000 Hubei, Wuhan, Hongshan lion street, Xiyuan District, No. 19, No. 58-1 Patentee after: Zhang Xinjun Address before: 430199 Nanyang Hubei province Tianmen Qiaoxiang Road Economic Development Zone No. 1 Patentee before: HUBEI TIANJI HONEY TECHNOLOGY CO., LTD. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160831 Termination date: 20170706 |